News NatureCell Co.,Ltd.

Equities

A007390

KR7007390008

End-of-day quote Korea S.E. Other stock markets 23:00:00 13/05/2024 BST			5-day change	1st Jan Change
9,740 ^KRW	+1.46%		+0.10%	+21.90%

2023	NatureCell Co.,Ltd. announced that it has received KRW 5 billion in funding	CI
2023	NatureCell to Raise 5 Billion Won via Stock Sale	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NatureCell Co.,Ltd. announced that it has received KRW 5 billion in funding	28/06/23	CI
NatureCell to Raise 5 Billion Won via Stock Sale	14/06/23	MT
NatureCell Co.,Ltd. announced that it expects to receive KRW 5 billion in funding	12/06/23	CI
NatureCell Co.,Ltd. announced that it has received KRW 11 billion in funding	09/05/23	CI
NatureCell to Raise 11 Billion Won in Stock Sale; Shares Rise 3%	02/05/23	MT
NatureCell Co.,Ltd. announced that it expects to receive KRW 11 billion in funding	01/05/23	CI
NatureCell Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23/03/23	CI
NatureCell Co.,Ltd. announced that it has received KRW 30 billion in funding	19/05/22	CI
NatureCell Co.,Ltd. announced that it expects to receive KRW 30 billion in funding	11/04/22	CI
R Bio Co.,Ltd. agreed to acquire 9.01% stake in NatureCell Co.,Ltd. from Biostar Korea Co., Ltd.	24/05/21	CI
NatureCell Co.,Ltd. announced that it has received KRW 10 billion in funding	25/08/20	CI
NatureCell Co.,Ltd. announced that it expects to receive KRW 10 billion in funding	23/08/20	CI
NatureCell Co.,Ltd. cancelled the acquisition of 2.3% stake in JASC Co., Ltd.	10/12/19	CI
NatureCell Co.,Ltd. agreed to acquire additional 2.3% stake in JASC Co., Ltd. for KRW 1.8 billion.	11/12/18	CI
Nature Cell Starts Commercial Clinical Trials Phase I and II ‘ASTROSTEM,’ Stem Cell Drug for Alzheimer's Disease Treatment in U.S	10/03/17	CI
Nature Cell Co.,Ltd. Receives U.S. FDA Approval for Phase I and II Alzheimer's Clinical Trial	28/11/16	CI
NatureCell Co.,Ltd.(KOSDAQ:A007390) added to S&P Global BMI Index	19/09/16	CI
Nature Cell Co.,Ltd. announced that it has received KRW 5 billion in funding	19/07/16	CI
Nature Cell Co.,Ltd. announced that it expects to receive KRW 5 billion in funding	29/06/16	CI
Sejong Life Science Laboratory sold 0.09% stake in Nature Cell Co.,Ltd. for approximately KRW 230 million.	15/05/16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News NatureCell Co.,Ltd.

Equities

A007390

KR7007390008

Summary

Filters